Toggle Main Menu Toggle Search

Open Access padlockePrints

Impact of donor transaminases on liver transplant utilisation and unnecessary organ discard: national registry cohort study

Lookup NU author(s): Dr Sam Tingle, Dr Emily ThompsonORCiD, Dr George KourounisORCiD, Professor Stuart McPhersonORCiD, Steven White, Professor Colin Wilson

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

2024 Dobbins, Tingle, Mehew, Thompson, Kourounis, McPherson, White and Wilson. Background: Donor liver transaminases (ALT and AST) have been used to decline livers for transplant, despite evidence that they do not influence transplant outcomes. This study assesses the effect that raised donor transaminases have on the unnecessary decline of livers. Methods: This retrospective cohort study used the National Health Service registry on adult liver transplantation (2016–2019). Logistic regression models were built to assess the impact of donor transaminases on the utilisation of organs donated following brain stem death (DBD) and circulatory death (DCD). A further model was used to simulate the impact on liver decline if raised donor ALT was not used to make utilisation decisions. Results: 5,424 adult livers were offered for transplant, of which 3,605 were utilised (2,841 DBD, 764 DCD). In multivariable analysis, adjusted for key factors, increasing peak donor ALT independently increased the odds of liver decline (DBD aOR = 1.396, 1.305–1.494, p < 0.001, DCD aOR = 1.162, 1.084–1.246, p < 0.001). AST was also a significant predictor of liver decline. 18.5% of livers from DBD donors with ALT > 40 U/L (n = 1,683) were declined for transplantation. In this group, our model predicted a 48% (38%–58%) decrease in decline if raised donor ALT was excluded from these decisions. This represents an additional 37 (30–45) liver transplants every year in the UK. Conclusions: Raised donor ALT increased the likelihood of liver decline. As it does not influence transplant outcome, avoiding donor ALT-based organ decline is an immediate and effective way to expand the donor pool.


Publication metadata

Author(s): Dobbins JJ, Tingle SJ, Mehew J, Thompson ER, Kourounis G, McPherson S, White SA, Wilson CH

Publication type: Article

Publication status: Published

Journal: Frontiers in Transplantation

Year: 2024

Volume: 3

Online publication date: 04/09/2024

Acceptance date: 06/08/2024

Date deposited: 02/10/2024

ISSN (electronic): 2813-2440

Publisher: Frontiers Media SA

URL: https://doi.org/10.3389/frtra.2024.1458996

DOI: 10.3389/frtra.2024.1458996

Data Access Statement: The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
MRC CRTF: MRC/Y000676/1
National Institute for Health and Care Research (NIHR) Blood and Transplant Research Unit in Organ Donation and Transplantation (NIHR203332)

Share